Projects per year
Organisation profile
Organisation profile
The Unit of HIV & Neglected Tropical Diseases was created in April 2015, building on the post-doctoral work of the current head (Johan van Griensven, internist/clinical epidemiologist).
The unit studies the interaction between neglected tropical diseases and other conditions such as HIV coinfection. The current main research area is visceral leishmaniasis (VL)-HIV coinfection in East-Africa. Research is conducted within a research collaboration including Gondar University (Ethiopia), the Drugs for Neglected Diseaseses initiative (DNDi) and Médecins sans Frontières (MSF). Within this network, clinical trials have been conducted, evaluating approaches for improving treatment outcomes (combination therapy) and preventing relapse (secondary prophylaxis) in VL patients. An innovative approach towards a VL screen & treat strategy in HIV infected patients at risk of developing VL is currently under study.
Key ambitions for the next years include expanding clinical research projects towards cutaneous leishmaniasis, and consolidating clinical immunological work linked to the clinical research projects.
The unit was also extensively involved in the 2013-2015 Ebola outbreak in West-Africa, with the unit head acting as coordinating investigator of a clinical trial evaluation the use of convalescent plasma as a treatment for Ebola in Guinea (REF).
Research lines:
- Diagnosis and prediction of VL-HIV coinfection
- Treatment of VL-HIV coinfection and cutaneous leishmaniasis
- Clinical epidemiology of VL-HIV coinfection
- Clinical immunological monitoring of VL-HIV coinfection
- Immunopathogenesis of VL-HIV coninfection
- Clinical research during infectious disease outbreaks in resource-constrained settings
As to capacity building, the unit is leading a research and training capacity building project with the University of Gondar, funded by the Belgian government. Education and training activities cover the short course on research methods and evidence based medicine (SCREM), of which the unit head is the course director, contributions to the online antiretroviral treatment course (eSCART) and the training activities conducted within the capacity building project in Gondar.
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Towards better diagnostics and a simplified treatment regimen for visceral leishmaniasis in southern Ethiopia
Degaga, T. S., van Griensven, J., Pareyn, M., Dujardin, J., Hailu, A. & Diro, E.
1/01/23 → …
Project: PhD-project
-
A framework to deduce the convoluted repertoire and epitope hierarchy of human T cell responses in visceral leishmaniasis: patient meets in silico
de Vrij, N., van Griensven, J., Adriaensen, W., Laukens, K., Cuypers, B., Cuypers, B. & Pham, T.
3/11/20 → …
Project: PhD-project
-
Improving the evidence base for diagnosis and management of cutaneous leishmaniasis in Ethiopia
van Henten, S., van Griensven, J. & Moons, J.
17/04/20 → …
Project: PhD-project
Research output
-
Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virus
ITM MPX Study Group, 2023, In: Journal of Clinical Virology. 159, 4 p., 105372.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile98 Downloads (Pure) -
Atypical mucocutaneous leishmaniasis presentation mimicking rectal cancer
Fikre, H., Teklehaimanot, E., Mohammed, R., Mengistu, M., Abebe, B., van Griensven, J. & van Henten, S., 2023, In: Case Reports in Infectious Disease. 2023, p. 2768626 4 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile99 Downloads (Pure) -
Characteristics of confirmed mpox cases among clinical suspects: a prospective single-centre study in Belgium during the 2022 outbreak
ITM Monkeypox Study Group, 2023, In: New Microbes and New Infections. 52, p. 101093 7 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile97 Downloads (Pure)